no image available Dickens & Co. "A New Frontier in Heart Care: A Breakthrough in Bioresorbable Vascular Scaffold Technology" "A Head-to-Head Comparison with Everolimus-Eluting Stents in Primary Percutaneous Coronary Interventions: A Game-Changer for Patient Outcomes?" Price: 27.00€